+ All Categories
Home > Documents > Gout Lecture

Gout Lecture

Date post: 02-Apr-2018
Category:
Upload: drusmanjamilhcmd
View: 220 times
Download: 0 times
Share this document with a friend

of 25

Transcript
  • 7/27/2019 Gout Lecture

    1/25

    B Y :

    D R M E H R U N N I S A U M A R

    A S S I S S T A N T P R O F E S O R

    D E P A R T M E N T O F M E D I C I N E

    CRYSTAL INDUCED

    ARTHROPATHIES

  • 7/27/2019 Gout Lecture

    2/25

    Two main types of crystals:

    - Sodium Urate &

    - Calcium pyrophosphate crystals

    Rarely- Crystals of cholesterol or

    - Calcium apatite

    cause acute synovitis.

    Diffrentiated by their shapes and properties.

  • 7/27/2019 Gout Lecture

    3/25

  • 7/27/2019 Gout Lecture

    4/25

    Epidemiology

    Affects less than 0.5% of the population

    Due to familial disposition, incidence may be as high as80% in families affected by disorder.

    Men > Women =10:1

    over30 years.

    About 90% with Primary gout are men.

    In women onset is typically postmenopausal

  • 7/27/2019 Gout Lecture

    5/25

    Pathogenesis

    Hyperuricemia is the major determinant fordeveloping gout.

    Uric acid levels depends upon the balance between:- Purine synthesis + ingestion of dietry purines

    &

    - excretion of uric acid by the kidneys.

    Urate saturates in plasma at 7 mg/dLAssuming pH, temp, Na are WNL

  • 7/27/2019 Gout Lecture

    6/25

    Uric Acid Metabolism

    Synthesis:

    - Last step in the purine metabolism pathway.

    - conversion of :

    Hypoxanthine Xanthine - Uric acid- Catalyzed by enzyme Xanthine Oxidase.

    Excretion:- Completely filtered by glomerulus

    - 98-100% reabsorbed by the proximal tubule.

    - 50% is secretted by the distal tubule.

  • 7/27/2019 Gout Lecture

    7/25

    Causes of Hyperuricemia

    Impaired Excretion: (90%)

    - Chronic renal disease- Hypertension

    - Lead therapy

    - Hyperparathroidism

    - Hypothyroidism

    - Inc. lactic acid production-due to:

    - Alcohol - Exercise - Starvation

    - Drug therapy:

    - Thiazide diuretics - Low dose Aspirin

  • 7/27/2019 Gout Lecture

    8/25

    Increased production of Uric acid (10%)

    - Inc. purine synthesis due to:

    - Lesch Nyhan Syndrome

    - Phosphoribosyl pyrophosphate synthetase overactivity- G6PD deficiency (inc production +dec excretion)

    - Inc. turnover of purines due to:

    - Myeloproliferative disorders (Polycythemia Vera)

    - Lymphoproliferative disorders (leukemia, lymphoma)- carcinoma

    - Severe Psoriasis

  • 7/27/2019 Gout Lecture

    9/25

  • 7/27/2019 Gout Lecture

    10/25

    Typical sequence involves progression through:

    Asymptomatic hyperuricemia

    Acute gouty arthritis

    Interval or intercritical gout

    Chronic or tophaceous gout

  • 7/27/2019 Gout Lecture

    11/25

    Types Of Gout

    Primary gout: Overproducers: 10%

    Under-excretors: 90%

    Secondary gout: Excess nucleoprotein turnover (lymphoma, leukemia)

    Increased cell proliferation/death (psoriasis)

    Rare genetic disorder Lesch-Nyan Syndrome

    Pharmaceuticals(diuretics,low dose aspirin,cyclosporin)

    Alcohol

  • 7/27/2019 Gout Lecture

    12/25

    Signs and Symptoms

    Acute attack: Over hours frequently nocturnal

    Excruciating pain

    Swelling, redness and tenderness

    Podagra: 1st

    MTP classic presentation May effect knees, wrist, elbow, and rarely SI and hips.

    Chronic:

    Destructive tophacous arthritis Much greater chance if untreated

    Rarely presents as a chronic condition

    http://www.hkma.com.hk/english/cme/pictquiz/pictquiz200112img2b.jpg
  • 7/27/2019 Gout Lecture

    13/25

    Diagnosis

    Based on history and physical exam

    Confirmed by Arthrocentesis Urate crystals: needle-shaped negatively

    birefringent either free floating or withinneutrophils & macrophages.

    Uric acid level non specific. 30% may show normal level

    24 hrs Urine collection: 800 mg ------- Overproducers

  • 7/27/2019 Gout Lecture

    14/25

    Microscopic Diagnosis

  • 7/27/2019 Gout Lecture

    15/25

    Radiology

    -Acute Soft tissue swelling

    Chronic Chronic tophaceous gouty arthritis,

    extensive bony erosions are notedthroughout the carpal bones

    Sclerosis and joint-space narrowing are

    seen in the first metatarsophalangeal joint,as well as in the fourth interphalangealjoint .

    http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom?picture=/websites/emedicine/radio/images/Large/52513898Gout;X-ray-foot.jpg&template=izoom2http://www.emedicine.com/cgi-bin/foxweb.exe/makezoom@/em/makezoom?picture=/websites/emedicine/radio/images/Large/52523899Gout;X-ray-hand.jpg&template=izoom2
  • 7/27/2019 Gout Lecture

    16/25

    Treatment

    Acute:

    NSAIDs anti-inflammatory doses- Naproxen -Indomethacin or- Diclofenac

    Colchicine- Started in acute attack.- Stop if no response or side effects.- Causes bone marrow suppression.

    Corticosteroids- Intramuscular or- Intra-articular depot methylprednisolone.

  • 7/27/2019 Gout Lecture

    17/25

    Treatment

    Chronic:

    Dietry advice:

    - Diet will decrease uric acid 1 mg/dL at best

    - Dec alcohol intake

    - Avoid foods rich in purines such as sea food, Spinach etc.

    - Weight loss

    Modification of medications

    Avoid low dose ASA, diuretics, etc.

  • 7/27/2019 Gout Lecture

    18/25

    Treatment

    Uricosuric drugs: for under-excretors

    Probenicid:

    Sulfinpyrazone: toxic side effects

    Avoid with renal disease

    Consider NSAIDs to avoid exacerbation of gout

    Should not be started within a month of acute attack

  • 7/27/2019 Gout Lecture

    19/25

    Treatment

    Indications for Allopurinol (xanthine Oxidase inhibitor)

    Tophaceous deposites

    Uric acid consistently >9

    Persistent symptoms with moderate UA levels

    Impaired renal function

    Prophylaxis for tumor-lysis syndrome

    Consider NSAIDs to avoid exacerbation

  • 7/27/2019 Gout Lecture

    20/25

    Prognosis

    Generally good

    More severe course when Symptoms present at less

    than 30 yrs of age

    Up to 50% progress to chronic disease if untreated.

    Surgical intervention may be required for tophi.

  • 7/27/2019 Gout Lecture

    21/25

    PSEUDOGOUT

    Characterized by calcium pyrophosphate deposits inhyaline and fibrocartilage.

    Leads to chondrocalcinosis

    Resembles Gout in presentation

    More common in elderly females

    Usually effects knee or wrist joints.

  • 7/27/2019 Gout Lecture

    22/25

    In young people it is associated with:

    - Haemochromatosis

    - Hyperparathyroidism

    -Wilsons disease

    - Alkaptonuria

  • 7/27/2019 Gout Lecture

    23/25

    Diagnosis

    Joint Fluid Aspiration:

    - Rhomboid shaped, weakly positively

    briefringent crystals

    Radiology:

    - Chondrocalcinosis on X Ray of joints.

  • 7/27/2019 Gout Lecture

    24/25

    TREATMENT

    Aspiration of jointreduces pain.

    NSAIDs

    Colchicine

    Corticosteroidsintra articularAfter exclusion of infection.

  • 7/27/2019 Gout Lecture

    25/25

    THANK YOU


Recommended